We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Find out more


Fourth Edition

Jerry Meyer

10 August 2022

ISBN: 9781605359878

816 pages

In Stock

Price: £101.99



.Unique in its breadth of coverage ranging from historical accounts of drug use to clinical and preclinical behavioral studies, Psychopharmacology is appropriate for undergraduates studying the relationships between the behavioral effects of psychoactive drugs and their mechanisms of action.

  • Enhanced ebook with integrated animations, web-links, flashcards, and self-assessment questions

About the Author(s)

Jerry Meyer, University of Massachussetts (Amherst)

Jerrold S. Meyer is Professor Emeritus of Psychology and former Director of the interdeparmental Neuroscience and Behavior Program at the University of Massachusetts, Amherst. Andrew M. Farrar is a Lecturer in the College of Natural Sciences at the University of Massachusetts Amherst and previously worked as a research scientist in academia and the pharmaceutical industry. Dominik Biezonski is a Senior Scientist in Preclinical Development at Prevail Therapeutics, which focuses on developing gene therapies for neurodegenerative diseases. Jennifer R. Yates is the Assistant Provost for Faculty Development, Teaching, & Learning, Director of the Center for Faculty Excellence, and Professor of Psychological Science at Lander University

Table of Contents

    Chapter 1. Principles of Pharmacology
    Chapter 2. Structure and Function of the Nervous System
    Chapter 4. Methods of Research in Psychopharmacology
    Chapter 5. Catecholamines
    Chapter 6. Serotonin
    Chapter 7. Acetylcholine
    Chapter 8. Glutamate and GABA
    Chapter 9. Drug Abuse and Addiction
    Chapter 10. Alcohol
    Chapter 11. The Opioids
    Chapter 12. Psychomotor Stimulants: Cocaine, Amphetamine, and Related Drugs
    Chapter 13. Nicotine and Caffeine
    Chapter 14. Marijuana and the Cannabinoids
    Chapter 15. Hallucinogens, PCP, and Ketamine
    Chapter 16. Inhalants, GHB, and Anabolic-Androgenic Steroids
    Chapter 17. Disorders of Anxiety and Impulsivity and the Drugs Used to Treat These Disorders
    Chapter 18. Affective Disorders: Antidepressants and Mood Stabilizers
    Chapter 19. Schizophrenia: Antipsychotic Drugs
    Chapter 20. Neurodegenerative Diseases, by Jennifer R. Yates, Lander University

Related Titles